RxSight, Inc. Income Tax Expense (Benefit), Intraperiod Tax Allocation
RxSight, Inc. (RXST) reported Income Tax Expense (Benefit), Intraperiod Tax Allocation of $34.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation · last filed 2026-02-25
- RxSight, Inc. income tax expense (benefit), intraperiod tax allocation for fiscal 2025 was $34.00K.
- RxSight, Inc. income tax expense (benefit), intraperiod tax allocation for fiscal 2024 was -$42.00K.
- RxSight, Inc. income tax expense (benefit), intraperiod tax allocation for fiscal 2023 was -$21.00K.
| Period end | Income Tax Expense (Benefit), Intraperiod Tax Allocation 12 month |
|---|---|
| 2025-12-31 | $34.00K 10-K · filed 2026-02-25 |
| 2024-12-31 | -$42.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | -$21.00K 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |